Ban on long-acting beta agonists for asthma

>
By  |  December 26, 2008 | 

An FDA advisory panel has voted to ban the use of serevent (salmeterol) and foradil (formoteral) for the treatment of asthma, based on a comprehensive review of literature indicating that beta-agonist monotherapy for asthma is associated with higher risk of severe asthma exacerbations and possibly a higher risk of death (FDA site). For now, these agents should not be used as monotherapy for the treatment of asthma in children or adults.

Share This Post

Leave A Comment

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

About the Author: Danielle Scheurer

Danielle Scheurer, MD, MSCR, SFHM is a clinical hospitalist and the Chief Quality Officer at the Medical University of South Carolina in Charleston, South Carolina, where she also serves as Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She is also the President of SHM's Board of Directors and previously served as Physician Editor of The Hospitalist, SHM's monthly newsmagazine.

Categories

Related Posts

By Angela Castellanos, MD
January 5, 2021 |  0
While spring 2020 feels like a lifetime ago, COVID-19 is still with us. Unfortunately, this winter has brought more infections, hospitalizations, and death rates that eclipse what many saw last spring. But this time, while the headlines are back about hospitals running low on PPE, ICU bed shortages, and long lines for testing, we now […]
By W. Michael Brode, MD
December 15, 2020 |  2
This article is part of a series in The Hospital Leader written by members of the Division of Hospital Medicine at Dell Medical School at The University of Texas in Austin, exploring lessons learned from the coronavirus pandemic and outlining an approach for creating COVID-19 Centers of Excellence. Evidence on emerging treatments for COVID-19 has […]
July 31, 2020 |  0
While all of us see patients who smoke in their 70s or 80s, due to their limited lifespan from COPD, DM, malignancy, etc., and their expressed wishes to continue tobacco, we keep our admonitions to a minimum. We accept our patient has become learned enough through life to make their own decisions and accept whatever […]
Go to Top